[4] Greenhaff PL, et al, 2006: Insulin stimulates L-carnitine accumulation in human skeletal muscle
In the Phase 3 trials, nausea was reported by approximately 44% of patients on Wegovy (semaglutide 2.4 mg) and approximately 28% of patients on Zepbound (tirzepatide 15 mg) during dose titration, usually mild to moderate and usually improving with time and dose stabilization
But the medications arent without side effects
Research by Lindsay Bodell, one of the authors of this story, and her colleagues on weight suppression may help explain why effects of semaglutides diminish over time, as weight suppression is associated with reduced GLP-1 response
Stomach pain, especially in the upper right side, where the liver sits
Bulk volumes priced on request